[文献资料]主要参考文献

Cel cycle，CDKs and cancer：a changing paradigm .Nat Rev Cancer，2009，9：153‐166.BI6727，a polo‐like kinase inhibitor with improved pharmacokinetic profile and broad antitumor activity .Na，a novel modulator of the Po lo‐like kinase1pathway，in adult patients wi ......